Erratum: MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop (J Clin Invest. (2012) 122:1 (33-47) DOI: 10.1172/JCI58849);MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/ IκBα negative feedback loop

Journal of Clinical Investigation

Volumn 122, Issue 1, 2012, Pages 33-47

  Jiang, Lili ^a,b   Lin, Chuyong ^a,b   Song, Libing ^b   Wu, Jueheng ^a,b   Chen, Baixue ^a,b   Ying, Zhe ^a,b   Fang, Lishan ^a,b   Yan, Xiao ^a,b   He, Mian ^a,b   Li, Jun ^a,b   Li, Mengfeng ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JSH 23; MATRIX METALLOPROTEINASE INHIBITOR; MICRORNA; MICRORNA 30E; NEUTRALIZING ANTIBODY; SN 50; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; MIRN30 MICRORNA, HUMAN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIGENETICS; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; TUMOR GROWTH; UPREGULATION; XENOTRANSPLANTATION; ANIMAL; BIOLOGICAL MODEL; BRAIN TUMOR; CANCER TRANSPLANTATION; CULTURE MEDIUM; FEEDBACK SYSTEM; GENETIC EPIGENESIS; GENETICS; GLIOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; EPIGENESIS, GENETIC; FEEDBACK, PHYSIOLOGICAL; GLIOMA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; I-KAPPA B PROTEINS; MICE; MICE, NUDE; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84855461449     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI155916     Document Type: Erratum

References (53)

1. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46(5):705-716. (Pubitemid 16020062)
2. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683.
3. Chen LF, Greene WC. 2004. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol. 2004; 5(5):392-401.
4. Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev. 2008;18(1):19-26.
5. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999; 18(49):6938-6947.
6. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109(suppl):S81-S96.
7. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8(1):49-62. (Pubitemid 46012014)
8. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18(18):2195-2224.
9. Sun SC, Ganchi PA, Ballard DW, Greene WC. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science. 1993;259(5103):1912-1915. (Pubitemid 23124465)
10. Johnson C, Van Antwerp D, Hope TJ. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IkappaBalpha. Embo J. 1999;18(23):6682-6693.
11. Huang TT, Kudo N, Yoshida M, Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A. 2000;97(3):1014-1019. (Pubitemid 30080804)
12. Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996. (Pubitemid 40349501)
13. Holland EC. Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet. 2001;2(2):120-129. (Pubitemid 33674003)
14. Reardon DA, Rich JN, Friedman HS, Bigner DD. Recent advances in the treatment of malignant astrocytoma. J Clin Oncol. 2006;24(8):1253-1265. (Pubitemid 46622028)
15. Maher EA, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001; 15(11):1311-1333. (Pubitemid 32524640)
16. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med. 2005; 353(8):811-822.
17. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer. 2002; 2(8):616-626. (Pubitemid 37328928)
18. Sherer HJ. The forms of growth in glioma and their practical significance. Brain. 1940;63(1):1-35.
19. Hoelzinger DB, Demuth T, Berens ME. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst. 2007;99(21):1583-1593. (Pubitemid 351767231)
20. Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D. Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol. 2005;15(4):297-310. (Pubitemid 41677429)
21. Kargiotis O, Rao JS, Kyritsis AP. Mechanisms of angiogenesis in gliomas. J Neurooncol. 2006; 78(3):281-293. (Pubitemid 44018823)
22. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610-622. (Pubitemid 47093931)
23. Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007;7(10):733-736. (Pubitemid 47463683)
24. Folkman J. Angiogenesis. Annu Rev Med. 2006;57:1-18.
25. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer. 1996;77(2):362-372. (Pubitemid 26023356)
26. Birlik B, Canda S, Ozer E. Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas. Neuropathol Appl Neurobiol. 2006;32(5):532-538. (Pubitemid 44401515)
27. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350- 355. (Pubitemid 39265675)
28. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297.
29. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005;65(9):3509-3512. (Pubitemid 40616320)
30. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-866. (Pubitemid 44629897)
31. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-269.
32. Ruvkun G. Clarifications on miRNA and cancer. Science. 2006;311(5757):36-37.
33. Ro S, Park C, Young D, Sanders KM, Yan W. Tissuedependent paired expression of miRNAs. Nucleic Acids Res. 2007;35(17):5944-5953.
34. Ghildiyal M, Xu J, Seitz H, Weng Z, Zamore PD. Sorting of Drosophila small silencing RNAs partitions microRNA*strands into the RNA interference pathway. Rna . 2010;16(1):43-56.
35. Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, Zehner ZE. MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clin Exp Metastasis. 2009;26(8):965-979.
36. Epis MR, Giles KM, Barker A, Kendrick TS, Leedman PJ. miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. J Biol Chem. 2009;284(37):24696-24704.
37. Gabriely G, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008;28(17):5369-5380.
38. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer. 2009; 125(6):1407-1413.
39. Nass D, et al. MiR-92b and miR-9/9*are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 2009;19(3):375-383.
40. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008; 455(7216):1061-1068.
41. Mariani L, et al. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol. 2001;53(2):161-176. (Pubitemid 33034689)
42. Hoelzinger DB, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia. 2005;7(1):7-16. (Pubitemid 40209466)
43. Hosako H, Martin GS, Barrier M, Chen YA, Ivanov IV, Mirkes PE. Gene and microRNA expression in p53-deficient day 8.5 mouse embryos. Birth Defects Res A Clin Mol Teratol. 2009;85(6):546-555.
44. Schotte D, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia. 2009; 23(2):313-322.
45. Jiang J, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res. 2008; 14(2):419-427. (Pubitemid 351226109)
46. Li J, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res. 2008; 14(11):3319-3326.
47. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer. 2002;2(5):331-341. (Pubitemid 37328946)
48. Shin HM, et al. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett. 2004;571(1-3):50-54.
49. Schetter AJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Jama . 2008;299(4):425-436. (Pubitemid 351185951)
50. Célérier J, Cruz A, Lamandé N, Gasc JM, Corvol P. Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension. 2002;39(2):224-228. (Pubitemid 34165219)
51. Zilberberg L, et al. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem. 2003;278(37):35564-35573. (Pubitemid 37102329)
52. Soroceanu L, Manning TJ Jr, Sontheimer H. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia. 2001;33(2):107-117. (Pubitemid 32160974)
53. Saeed AI, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003;34(2):374-378. (Pubitemid 36184095)